iSpecimen (ISPC) Income from Non-Controlling Interests (2022 - 2023)

iSpecimen (ISPC) posted quarterly Income from Non-Controlling Interests of $2.1 million for Q3 2023, down 31.8% year-over-year from $3.1 million in Q3 2022, and down 39.71% on a QoQ basis from $3.5 million in Q2 2023.

iSpecimen (ISPC) Income from Non-Controlling Interests (2022 - 2023) Analysis & Trends

iSpecimen (ISPC) has reported Income from Non-Controlling Interests for 2 consecutive years, with $2.1 million the latest figure, recorded in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Waters 31,055.11 Bn 31,054.65 Bn 1.11 Bn -
2 Thermo Fisher Scientific 191.02 Bn 187.77 Bn 7.74 Bn 5.00 Mn
3 Danaher 137.16 Bn 131.47 Bn 3.59 Bn -
4 Idexx Laboratories 42.82 Bn 42.62 Bn 722.74 Mn -
5 Natera 39.09 Bn 37.99 Bn 696.04 Mn -
6 Agilent Technologies 37.61 Bn 35.81 Bn 990.00 Mn -
7 Iqvia Holdings 34.23 Bn 32.25 Bn 1.36 Bn 1.00 Mn
8 Illumina 28.14 Bn 26.98 Bn 721.00 Mn -
9 Mettler Toledo International 26.40 Bn 26.33 Bn 555.82 Mn -
10 iSpecimen 931,959.22 -1.89 Mn -1.39 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2023 2.11 Mn
Jun 30, 2023 3.50 Mn
Mar 31, 2023 2.41 Mn
Sep 30, 2022 3.10 Mn
Jun 30, 2022 2.61 Mn
Mar 31, 2022 2.38 Mn